<DOC>
	<DOCNO>NCT02889211</DOCNO>
	<brief_summary>The purpose study help researcher learn brain responds reward . This study interest see response differ people less responsive insulin body , people without depression .</brief_summary>
	<brief_title>Brain Function Depression Insulin Resistance</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>HEALTHY CONTROLS HOMAIR ( fast ( glucose x insulin ) /405 ) &lt; 1.8 Not one following : Waist circumference &gt; 40 inch ( men ) &gt; 35 inch ( woman ) Triglycerides &gt; 150 mg/dL HDL &lt; 40 mg/dL ( men ) &lt; 50 mg/dL ( woman ) Blood pressure &gt; 135/85 Fasting glucose &gt; 100 mg/dL INSULIN RESISTANT HOMAIR &gt; 2.0 And least three follow : Waist circumference &gt; 40 inch ( men ) &gt; 35 inch ( woman ) Triglycerides &gt; 150 mg/dL HDL &lt; 40 mg/dL ( men ) &lt; 50 mg/dL ( woman ) Blood pressure &gt; 135/85 Fasting glucose &gt; 100 mg/dL MAJOR DEPRESSION , METABOLICALLY HEALTHY Meets criterion MDD SCID5 evaluation HOMAIR &lt; 1.8 Not one following : Waist circumference &gt; 40 inch ( men ) &gt; 35 inch ( woman ) Triglycerides &gt; 150 mg/dL HDL &lt; 40 mg/dL ( men ) &lt; 50 mg/dL ( woman ) Blood pressure &gt; 135/85 Fasting glucose &gt; 100 mg/dL MAJOR DEPRESSION , INSULIN RESISTANT Meets criteria MDD SCID5 evaluation HOMAIR &gt; 2.0 And least three follow : Waist circumference &gt; 40 inch ( men ) &gt; 35 inch ( woman ) Triglycerides &gt; 150 mg/dL HDL &lt; 40 mg/dL ( men ) &lt; 50 mg/dL ( woman ) Blood pressure &gt; 135/85 Fasting glucose &gt; 100 mg/dL History mania psychosis Current suicidal ideation Alcohol substance abuse include cannabis use ( current last three month ) Early onset dementia etiology Medical condition know significant effect mood ( e.g . Stroke current hypothyroid state ) Unstable medical illness ( e.g . Delirium , uncontrolled DM , uncontrolled cardiovascular illness ) Use high dos benzodiazepine ( &gt; 2mg lorazepam/day equivalent ) Given high comorbidity ( 80 % ) MDD anxiety disorder , participant comorbid anxiety disorder include study long clinical presentation suggest depression precedes onset anxiety Current lifetime history cancer , chronic kidney liver condition , type I II diabetes Current lifetime use glucocorticoid medication &gt; 1 month Previous cerebrovascular accident trauma involve loss consciousness Previous neurosurgery history neurological condition Pregnancy ( female ) Claustrophobia Ferrous metallic implant surgically place medical device clear safety 3Tesla MRI strength Positive Hepatitis C serology know viral infection may induce insulin resistance Peripheral vascular disease Liver , kidney , active blood disease Peripheral neuropathy Fasting glucose &gt; 126 mg/dL Currently take medication alter glucose homeostasis ( steroid , glucocorticoid , nicotinic acid ) Currently take thiazolidinediones insulin Females currently hormone replacement therapy ( HRT ) less 6 month Being leave hand Use antidepressant medication within past two week ( six week fluoxetine ) Suicide risk Current use stimulant , antipsychotic medication , mood stabilizer , cognitive enhancer , statin , glucocorticoid , steroid , nicotinic acid , thiazolidinediones , insulin , metformin , diabetes medication ( e.g . gliptins ) , HIV medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>